Insider Trading29 Jun 2026, 03:53 pm
Jubilant Pharmova Closes Trading Window for Q1 FY27 Results
AI Summary
Jubilant Pharmova Limited has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the announcement of the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. Designated persons and their immediate relatives are prohibited from trading during this period. The date for the board meeting to declare these financial results will be communicated separately.
Key Highlights
- Trading window closed from July 1, 2026, for Q1 FY27 results.
- Applies to designated persons and immediate relatives.
- Aims to prevent insider trading as per SEBI regulations.
- Board meeting date for results declaration to be announced later.
Price Impact
More from JUBLPHARMA